Position history for Orbis Allan Gray Ltd's holdings in CRISPR THERAPEUTICS AG
Orbis Allan Gray Ltd holds 6M shares of CRSP (CRISPR THERAPEUTICS AG), worth $312M as of 2025-Q4. The position was increased (++19.4% shares). CRSP represents 1.3% of Orbis Allan Gray Ltd's portfolio.
Current Value
$312M
Current Shares
6M
Total Value Change
+$253.9M
Total Shares Change
+4.5M
Increased |
| 6M |
+19.4% |
| $312M |
| 1.3% |
| $53.19 |
58 |
| 2025-Q3 | Increased | 5M | +80.2% | $322.9M | 1.4% | $63.77 | 75 |
| 2025-Q2 | Increased | 2.8M | +76.9% | $134.5M | 0.7% | $47.49 | 65 |
| 2025-Q1 | Increased | 1.6M | +5.9% | $53.2M | 0.3% | $36.99 | 37 |
| 2024-Q4 | New | 1.5M | - | $58.1M | 0.3% | $38.65 | 49 |